Inventor · disambiguated record
Edwige Liliane Jeanne Lorthiois
Also filed as: LORTHIOIS EDWIGE · LORTHIOIS EDWIGE LILIANE · LORTHIOIS EDWIGE LILIANE JEANNE
15 granted patents·10 pending applications·105 citations·filing 2002–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0189US9468661B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Oct 18, 2016·17 cites·18 claims
- 0289US9085555B2Complement pathway modulators and uses thereofALTMANN EVA·Filed 2012·Granted Jul 21, 2015·26 cites·8 claims
- 0380US6753340B2(4,2-disubstituted-thiazol-5-yl)amine compounds as PDE7 inhibitorsWARNER LAMBERT CO·Filed 2003·Granted Jun 22, 2004·18 cites·19 claims
- 0479US9388199B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Jul 12, 2016·5 cites·14 claims
- 0577US9815819B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Nov 14, 2017·4 cites·20 claims
- 0677US6852720B2Thiazol-2-yl-imine compounds as PDE-7 inhibitorsPFIZER·Filed 2003·Granted Feb 8, 2005·13 cites·17 claims
- 0776US9550755B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Jan 24, 2017·3 cites·4 claims
- 0876US7214676B2Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitorsWARNER LAMBERT CO·Filed 2004·Granted May 8, 2007·12 cites·18 claims
- 0975US7456164B23- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligandsPFIZER·Filed 2005·Granted Nov 25, 2008·3 cites·23 claims
- 1072US9487483B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Nov 8, 2016·2 cites·17 claims
- 1172US9464081B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Oct 11, 2016·2 cites·13 claims
- 1268US2024382457A1Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1359US2024317721A1Pyrazolyl derivatives as inhibitors of the kras mutant proteinNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1458US12083101B2Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitorsNOVARTIS AG·Filed 2021·Granted Sep 10, 2024·0 cites·33 claims
- 1556US2024366567A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses thereof for the treatment of cancersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1655US2007049558A1New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 InhibitorsPFIZER·Filed 2006·Application pending·0 cites
- 1753US2024082218A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1852US12226405B2Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of useNOVARTIS AG·Filed 2021·Granted Feb 18, 2025·0 cites·30 claims
- 1951US2024116900A1New crystalline forms of a kras g12c inhibitor compoundNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2050US11702409B2Pyrazolyl derivatives useful as anti-cancer agentsNOVARTIS AG·Filed 2020·Granted Jul 18, 2023·0 cites·34 claims
- 2147US2002198198A1Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitorsFiled 2002·Application pending·0 cites
- 2245US2009281161A1Organic CompoundsMAIBAUM JUERGEN KLAUS·Filed 2007·Application pending·0 cites
- 2345US2009270417A1Organic CompoundsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2442US7807709B2Organic compoundsNOVARTIS AG·Filed 2006·Granted Oct 5, 2010·0 cites·7 claims
- 2542US2015191462A1Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →